Vascular Medicine最新文献_第9页

Society Communications: 2024 Committee Updates. 学会通讯：2024 委员会更新。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1177/1358863X241268675

Kevin P Cohoon, Daniella Kadian-Dodov, Robert Eberhardt, Aditya Sharma

引用次数: 0

Competing risk analysis to estimate amputation incidence and risk in lower-extremity peripheral artery disease. 通过竞争风险分析估算下肢外周动脉疾病的截肢发生率和风险。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-10-01 Epub Date: 2024-09-01 DOI: 10.1177/1358863X241268727

Santiago Callegari, Kim G Smolderen, Jacob Cleman, Carlos Mena-Hurtado, Gaëlle Romain

{"title":"Competing risk analysis to estimate amputation incidence and risk in lower-extremity peripheral artery disease.","authors":"Santiago Callegari, Kim G Smolderen, Jacob Cleman, Carlos Mena-Hurtado, Gaëlle Romain","doi":"10.1177/1358863X241268727","DOIUrl":"10.1177/1358863X241268727","url":null,"abstract":"Background: Patients with peripheral artery disease face high amputation and mortality risk. When assessing vascular outcomes, consideration of mortality as a competing risk is not routine. We hypothesize standard time-to-event methods will overestimate major amputation risk in chronic limb-threatening ischemia (CLTI) and non-CLTI. Methods: Patients undergoing peripheral vascular intervention from 2017 to 2018 were abstracted from the Vascular Quality Initiative registry and stratified by mean age (⩾ 75 vs < 75 years). Mortality and amputation data were obtained from Medicare claims. The 2-year cumulative incidence function (CIF) and risk of major amputation from standard time-to-event analysis (1 - Kaplan-Meier and Cox regression) were compared with competing risk analysis (Aalen-Johansen and Fine-Gray model) in CLTI and non-CLTI. Results: A total of 7273 patients with CLTI and 5095 with non-CLTI were included. At 2-year follow up, 13.1% of patients underwent major amputation and 33.4% died without major amputation in the CLTI cohort; 1.3% and 10.7%, respectively, in the non-CLTI cohort. In CLTI, standard time-to-event analysis overestimated the 2-year CIF of major amputation by 20.5% and 13.7%, respectively, in patients ⩾ 75 and < 75 years old compared with competing risk analysis. The standard Cox regression overestimated adjusted 2-year major amputation risk in patients ⩾ 75 versus < 75 years old by 7.0%. In non-CLTI, the CIF was overestimated by 7.1% in patients ⩾ 75 years, and the adjusted risk was overestimated by 5.1% compared with competing risk analysis. Conclusions: Standard time-to-event analysis overestimates the incidence and risk of major amputation, especially in CLTI. Competing risk analyses are alternative approaches to estimate accurately amputation risk in vascular outcomes research.","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"496-506"},"PeriodicalIF":3.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Original Research Abstracts Presented at the 2024 Vascular Scientific Sessions of the Society for Vascular Medicine 血管医学学会 2024 年血管科学会议上发表的原创研究摘要

IF 3.5 3区医学

Vascular Medicine Pub Date : 2024-09-12 DOI: 10.1177/1358863x241278092

引用次数: 0

Clinical Case Abstracts Presented at the 2024 Vascular Scientific Sessions of the Society for Vascular Medicine 血管医学学会 2024 年血管科学会议临床病例摘要

IF 3.5 3区医学

Vascular Medicine Pub Date : 2024-09-12 DOI: 10.1177/1358863x241278093

引用次数: 0

The influence of patient sex on pulmonary embolism evaluation, treatment modality, and outcomes. 患者性别对肺栓塞评估、治疗方式和结果的影响。

IF 3.5 3区医学

Vascular Medicine Pub Date : 2024-09-12 DOI: 10.1177/1358863x241281872

Joshua Newman,Elizabeth Bruno,Sorcha Allen,Jonathan Moore,Robert Zilinyi,Asma Khaliq,Fahad Alkhafan,Clara Vitarello,Robert Lookstein,Brent Keeling,C Michael Gibson,Kenneth Rosenfield,Eric A Secemsky,Rachel P Rosovsky,Amir Darki

{"title":"The influence of patient sex on pulmonary embolism evaluation, treatment modality, and outcomes.","authors":"Joshua Newman,Elizabeth Bruno,Sorcha Allen,Jonathan Moore,Robert Zilinyi,Asma Khaliq,Fahad Alkhafan,Clara Vitarello,Robert Lookstein,Brent Keeling,C Michael Gibson,Kenneth Rosenfield,Eric A Secemsky,Rachel P Rosovsky,Amir Darki","doi":"10.1177/1358863x241281872","DOIUrl":"https://doi.org/10.1177/1358863x241281872","url":null,"abstract":"BACKGROUNDPulmonary embolism (PE) is the third-leading cause of cardiovascular mortality, accounting for 100,000 deaths per year in the United States. Although sex-based disparities have previously been described in this population, it is unclear if these differences have persisted with the expansion of PE evaluation and treatment approaches. The purpose of this study is to investigate sex-based differences in the evaluation, management, and outcomes of patients with acute PE.METHODSWe performed a retrospective analysis of patients enrolled in the national Pulmonary Embolism Response Team (PERT) Consortium database between October 2015 and October 2022. We evaluated patient demographics, clinical characteristics, diagnostic imaging performed, treatment at several phases of care (pre-PERT, PERT recommendations, and post-PERT), and clinical outcomes.RESULTSA total of 5722 patients with acute PE (2838 [49.6%] women) from 35 centers were included. There were no differences in PE risk category between male and female patients. Women were less likely to undergo echocardiography (76.9% vs 73.8%) and more likely to receive no anticoagulation prior to PERT evaluation (35.5% vs 32.9%). PERT teams were more likely to recommend catheter-based interventions for men (26.6% vs 23.1%), and men were more likely to undergo these procedures (21.9% vs 19.3%). In a multivariable analysis, female sex was a predictor of in-hospital mortality (OR 1.53, 95% CI 1.06 to 2.21).CONCLUSIONSIn this analysis, we identified sex-based differences in the evaluation and management of patients presenting with acute PE. Subsequently, women presenting with acute PE were at higher risk of in-hospital mortality.","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":"10 1","pages":"1358863X241281872"},"PeriodicalIF":3.5,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142205639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Post-pulmonary embolism syndrome, CTEPD, and CTEPH. 血管疾病患者信息页面：肺栓塞后综合征、CTEPD 和 CTEPH。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-08-01 Epub Date: 2024-07-29 DOI: 10.1177/1358863X241258957

Mateo Porres-Aguilar, Belinda Rivera-Lebron, Nick H Kim, Alexandra L Solomon, Elizabeth V Ratchford, Gustavo A Heresi

引用次数: 0

Changes in the ankle-brachial index and progression of white matter hyperintensities of presumed vascular origin in community-dwelling older adults: A prospective population study. 社区老年人踝肱指数的变化与假定血管性白质高密度症的进展：一项前瞻性人口研究。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-08-01 Epub Date: 2024-06-03 DOI: 10.1177/1358863X241256299

Maitri Patel, Robertino M Mera, Denisse A Rumbea, Oscar H Del Brutto

引用次数: 0

Enterocolic lymphocytic phlebitis as a rare vascular cause of colitis. 血管医学图像：肠结肠淋巴细胞性静脉炎是结肠炎的罕见血管病因。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-08-01 Epub Date: 2024-04-01 DOI: 10.1177/1358863X241236774

Shantum Misra, Aaron Hakim, Martin P Smith, Vikram Deshpande, Jacqueline L Wolf, Brett J Carroll

引用次数: 0

Steering the multidisciplinary landscape of vascular medicine: Collaboration as the key to success for aspiring vascular medicine specialists. 引导血管医学的多学科发展：合作是有抱负的血管医学专家取得成功的关键。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-08-01 DOI: 10.1177/1358863X241262723

Kevin P Cohoon, Mateo Porres-Aguilar, Roger T Tomihama, Sneha E Thomas, Anthony Buckley, Everett Rogers, Nichole E Brunton, Stanislav Henkin, Deborah Hornacek, Eric A Secemsky

引用次数: 0

Five-year outcomes of the GORE VIABAHN Endoprosthesis for the treatment of complex femoropopliteal lesions from a Japanese postmarket surveillance study. 日本一项上市后监测研究显示，GORE VIABAHN假体治疗复杂股骨干病变的五年疗效。

IF 3 3区医学

Vascular Medicine Pub Date : 2024-08-01 Epub Date: 2024-03-27 DOI: 10.1177/1358863X241233528

Osamu Iida, Takao Ohki, Yoshimitsu Soga, Nobuhiro Suematsu, Tatsuya Nakama, Terutoshi Yamaoka, Kazuki Tobita, Shigeo Ichihashi

{"title":"Five-year outcomes of the GORE VIABAHN Endoprosthesis for the treatment of complex femoropopliteal lesions from a Japanese postmarket surveillance study.","authors":"Osamu Iida, Takao Ohki, Yoshimitsu Soga, Nobuhiro Suematsu, Tatsuya Nakama, Terutoshi Yamaoka, Kazuki Tobita, Shigeo Ichihashi","doi":"10.1177/1358863X241233528","DOIUrl":"10.1177/1358863X241233528","url":null,"abstract":"Introduction: The safety and effectiveness of the GORE VIABAHN Endoprosthesis for treatment of symptomatic patients with peripheral artery disease (PAD) and complex femoropopliteal (FP) lesions was assessed in a real-world Japanese practice setting. Methods: A prospective, multicenter, postmarket surveillance study was conducted from 2016 to 2017 at 64 sites in Japan. Symptomatic patients with PAD and FP lesions ⩾ 10 cm and reference vessel diameters ranging from 4.0 to 7.5 mm were eligible for enrollment. Outcome measures evaluated at 5 years were primary patency (PP), primary-assisted patency (PAP), secondary patency (SP), freedom from target lesion revascularization (fTLR), occurrence of device- or procedure-related serious adverse events (SAEs), and stent fractures. Results: A total of 321 patients were enrolled and were a mean age of 73.9 ± 8.7 years; 77.3% were men and 26.5% had chronic limb-threatening ischemia (CLTI). The mean lesion length was 23.6 ± 6.6 cm and the frequency with TASC II C/D lesions and chronic total occlusions was 86.6% and 70.4%, respectively. The Kaplan-Meier estimated PP, PAP, SP, and fTLR at 5 years was 62.4%, 74.1%, 82.3%, and 75.9%, respectively. The mean ankle-brachial index was 0.92 ± 0.15 and the mean improvement in Rutherford class was 2.3 ± 1.4, which was maintained through 5 years. The rate of cumulative device- or procedure-related SAEs through 5 years was 19.9% with only 9.3% of those occurring after the first year. No stent fractures were observed through 5 years by x-ray evaluation. Conclusion: The 5-year safety and efficacy outcomes of the endoprosthesis were clinically acceptable for treating complex FP lesions in a real-world cohort of Japanese patients with PAD. (ClinicalTrials.gov Identifier: NCT04706273).","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"416-423"},"PeriodicalIF":3.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0